IP Library Assignment 067184/0147
Patent Assignment
Reel/Frame 067184/0147

Assignment of Assignor's Interest

Recorded: 2024-04-22 Pages: 14
Assignor
2SEVENTY BIO, INC.
Executed: 2024-04-01
Assignee
REGENERON PHARMACEUTICALS, INC.
777 OLD SAW MILL RIVER RD, TARRYTOWN, NEW YORK, 10591-6707
Covered Properties (3)
CD33 Targeted Immunotherapies
Application: 17/608,743 →
Publication: US 2022/0324942
CD33 Targeted Immunotherapies
Application: 62/845,304 →
CD33 Targeted Immunotherapies
Application: 62/898,392 →
Related Assignments (11)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 22, 2019
From: JARJOUR, JORDAN; POGSON, MARK; LEUNG, WAI-HANG
To: BLUEBIRD BIO, INC.
Reel/Frame 049822/0539 →
Assignment of Assignor's Interest Aug 16, 2019
From: JONES, KYLE; CRAGO, WILLIAM; SANABRIA, ANGELICA; HOLLANDS, ANDREW
To: INHIBRX, INC.
Reel/Frame 050069/0679 →
Assignment of Assignor's Interest Nov 27, 2019
From: JARJOUR, JORDAN; POGSON, MARK; LEUNG, WAI-HANG
To: BLUEBIRD BIO, INC.
Reel/Frame 051130/0106 →
Assignment of Assignor's Interest Feb 25, 2020
From: JONES, KYLE; CRAGO, WILLIAM; SANABRIA, ANGELICA; HOLLANDS, ANDREW
To: INHIBRX, INC.
Reel/Frame 051913/0494 →
Assignment of Assignor's Interest Sep 14, 2021
From: BLUEBIRD BIO, INC.
To: 2SEVENTY BIO, INC.
Reel/Frame 057683/0099 →
Intellectual Property Security Agreement Feb 28, 2022
From: INHIBRX, INC.
To: OXFORD FINANCE LLC
Reel/Frame 059262/0780 →
Assignment of Assignor's Interest Mar 7, 2022
From: JARJOUR, JORDAN; POGSON, MARK; LEUNG, WAI-HANG
To: 2SEVENTY BIO, INC.
Reel/Frame 059181/0749 →
Assignment of Assignor's Interest Sep 1, 2022
From: JONES, KYLE; CRAGO, WILLIAM; SANABRIA, ANGELICA; HOLLANDS, ANDREW
To: INHIBRX, INC.
Reel/Frame 060970/0188 →
Release of Security Interest Jun 3, 2024
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: INHIBRX, INC.
Reel/Frame 067606/0247 →
Assignment of Assignor's Interest Jun 10, 2024
From: INHIBRX, INC.
To: INHIBRX BIOSCIENCES, INC.
Reel/Frame 067679/0338 →
Security Interest Jan 14, 2025
From: INHIBRX BIOSCIENCES, INC.
To: OXFORD FINANCE LLC; OXFORD FINANCE LLC
Reel/Frame 069894/0045 →